Recent News

• 12.10.2025 - Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
• 11.20.2025 - Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference
• 11.05.2025 - Ocugen Provides Business Update with Third Quarter 2025 Financial Results
• 10.23.2025 - Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
• 10.02.2025 - Ocugen to Present at Industry and Investor Conferences in October 2025
• 10.02.2025 - Ocugen to Present at Industry and Investor Conferences in October 2025
• 10.02.2025 - Ocugen to Present at Industry and Investor Conferences in October 2025
• 09.30.2025 - Elemer Piros
• 09.30.2025 - Elemer Piros
• 09.25.2025 - Biotech on Tap

Recent Filings

• 12.08.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.05.2025 - 8-K Current report
• 11.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.05.2025 - EX-99.1 EX-99.1
• 10.31.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 09.18.2025 - 8-K Current report
• 09.16.2025 - 8-K Current report